All of Us Research Program
Site Principal Investigator: Pamela Pawloski, Pharm.D., BCOP, FCCP
Study sponsor: National Institutes of Health (NIH)
-Regions Cancer Care Center
-HealthPartners Neuroscience Center
Purpose of study: HealthPartners Institute is part of the All of Us research program funded by the National Institutes of Health (NIH). The goal of the All of Us research program is to improve health for all of us, for generations to come. The research program is asking people across the United States to join and share their health information and other data to build a large research database that will inform future studies and may even help make the next big medical discovery.
If you are interested you can begin the enrollment process by creating an account online at JoinAllofUs.org. This will give you access to the Participant Portal where you can learn more about the study, complete consent forms, take health surveys, and begin the All of Us journey. If you are eligible, you will be invited to attend an in-person visit at one of our HealthPartners enrollment clinics to have your physical measurements taken and provide blood and urine samples. You will receive a $25 gift card if you are eligible and complete a clinic visit.
Inclusion Criteria: Patients 18 years old or older, current resident of the U.S., not incarcerated
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults (COVID-19 Vaccine Study in Minnesota)
Principal Investigators: Charlene McEvoy, MD, MPH; Zeke McKinney, MD
Study sponsor: AstraZeneca
Location: Bloomington, MN
Phase of Study: Phase III
Purpose of study: The AstraZeneca COVID-19 vaccine study is a clinical research study to evaluate an investigational vaccine for the prevention of COVID-19. In this study, participants will be randomly assigned (by chance) to receive 2 injections of either the investigational vaccine or placebo (4 weeks apart). A placebo looks like the investigational vaccine but contains no active vaccine. There is twice as much chance of receiving the investigational vaccine than of receiving the placebo. Study participation will last about 2 years.
-At least 18 years of age
-Are in good or stable health, including having a well-managed underlying medical condition
-Have an increased risk of getting COVID-19, like working in a close-contact profession
-Don’t have a previously confirmed COVID-19 diagnosis
Visit https://www.healthpartners.com/vaccinestudy for more information about the study and to complete the screening form.